Abstract 5336: Targeting glioma growth and invasiveness by microRNA-1.

Published on Apr 15, 2013in Cancer Research9.727
· DOI :10.1158/1538-7445.AM2013-5336
Jakub Godlewski29
Estimated H-index: 29
(Brigham and Women's Hospital),
Agnieszka Bronisz25
Estimated H-index: 25
(Brigham and Women's Hospital)
+ 1 AuthorsE. Antonio Chiocca79
Estimated H-index: 79
(Brigham and Women's Hospital)
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor. Median survival is about 14 months, even with the most effective regimen of surgery followed by radiation and chemotherapy. GBM is characterized by the hallmarks of cellular heterogeneity, rapid proliferation, angiogenesis and extensive invasion. The dual feature of high proliferation and infiltration constitutes the major challenge for glioma therapy, as even extensive resection of the primary tumor mass leaves a significant number of tumor cells in the brain and leads to almost unavoidable recurrence. Despite abundance of data concerning glioma growth/angiogenesis, the mechanisms underlying the regulation of glioma cell motility and invasiveness are comparatively poorly understood. Established anti-glioma therapeutical modalities (radiation, chemotherapy) target preferentially rapidly proliferating rather than infiltrating glioma cells. Moreover invading cells are resistant to conventional therapies, and anti-angiogenic treatment was shown to induce invasiveness. Thus novel therapies aiming at blockade of glioma invasion, while curbing their proliferative potential are needed. MicroRNAs (miRs) are small, single stranded, non-coding RNAs that act as key regulators of gene expression, by reducing translation of target mRNAs with partial complementarity in their 3′UTRs. MiRs deregulation is a general feature of cancer, including GBM, and was associated with tumor suppressor and oncogenic activities. A number of studies have identified critical roles for miRs in the regulation of tumor cell invasion, migration and metastasis. In this study we report that miR-1 is down-regulated in glioma patients (relatively to adjacent tissue) and that it is down-regulated in migrating glioma cells in vitro (relatively to non-migrating glioma cells). Its forced expression reduces glioma cell growth and angiogenesis in vivo. MiR-1 inhibits migration in vitro and invasiveness in vivo. Additionally, we demonstrated impaired cell-cell adhesion and aggregation in glioma cells expressing miR-1. We identified Annexin A2, recognized oncogene in glioma, as a direct target of miR-1. Annexin A2 is up-regulated in various tumor types, including glioma. In vivo studies revealed a critical role for Annexin A2 in driving glioma growth, angiogenesis, progression and invasion. Our results show that the effects of miR-1 on glioma cells are consistent with Annexin A2 down-regulation, including a reduction in glioma cell proliferation and invasiveness, and re-expression of Annexin A2 rescues the effect of miR-1 expression. When glioma cells stably expressing miR-1 were injected intracranially, we observed significantly improved survival when compared to control cells. Our results suggest that miR-1 inhibits simultaneously glioma growth and invasiveness in vivo and as such may be a candidate for the therapeutic targeting of glioma cells. Citation Format: Jakub A. Godlewski, Agnieszka Bronisz, Yan Wang, E. Antonio Chiocca. Targeting glioma growth and invasiveness by microRNA-1. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5336. doi:10.1158/1538-7445.AM2013-5336
📖 Papers frequently viewed together
123 Citations
2,634 Citations
5 Authors (Xiaogang Liu, ..., Bing Liu)
19 Citations
Cited By15
#1Emily Bell (Cornell University)H-Index: 22
#2Pragya Shah (Cornell University)H-Index: 5
view all 14 authors...
Abstract null Aberrations in nuclear size and shape are commonly used to identify cancerous tissue. However, it remains unclear whether the disturbed nuclear structure directly contributes to the cancer pathology or is merely a consequence of other events occurring during tumorigenesis. Here, we show that highly invasive and proliferative breast cancer cells have lower expression of the nuclear envelope proteins lamin A/C, leading to increased nuclear deformability that permits enhanced cell mig...
#1Amanpreet Kaur (UPenn: University of Pennsylvania)H-Index: 22
#2Brett L. Ecker (Wistar Institute)H-Index: 18
Last. Ashani T. Weeraratna (Wistar Institute)H-Index: 54
view all 30 authors...
Physical changes in skin are among the most visible signs of aging. We found that young dermal fibroblasts secrete high levels of extracellular matrix (ECM) constituents, including proteoglycans, glycoproteins, and cartilage-linking proteins. The most abundantly secreted was HAPLN1, a hyaluronic and proteoglycan link protein. HAPLN1 was lost in aged fibroblasts, resulting in a more aligned ECM that promoted metastasis of melanoma cells. Reconstituting HAPLN1 inhibited metastasis in an aged micro...
103 CitationsSource
#1Sarah Davidson (Medical Research Council)H-Index: 2
#2Mirjana Efremova (Wellcome Trust Sanger Institute)H-Index: 16
Last. Sarah A. TeichmannH-Index: 102
view all 13 authors...
Non-cancerous stromal cells represent a highly diverse compartment of the tumour, yet their role across tumour evolution remains unclear. We employed single-cell RNA sequencing to determine stromal adaptations in murine melanoma at different points of tumour development. Naive lymphocytes recruited from lymph nodes underwent activation and clonal expansion within the tumour, prior to PD1 and Lag3 expression, while tumour-associated myeloid cells promoted the formation of a suppressive niche thro...
13 CitationsSource
#1Jason J. Northey (UCSF: University of California, San Francisco)H-Index: 10
#2Laralynne Przybyla (UCSF: University of California, San Francisco)H-Index: 7
Last. Valerie M. Weaver (UCSF: University of California, San Francisco)H-Index: 87
view all 3 authors...
Biomechanical and biochemical cues within a tissue collaborate across length scales to direct cell fate during development and are critical for the maintenance of tissue homeostasis. Loss of tensional homeostasis in a tissue not only accompanies malignancy but may also contribute to oncogenic transformation. High mechanical stress in solid tumors can impede drug delivery and may additionally drive tumor progression and promote metastasis. Mechanistically, biomechanical forces can drive tumor agg...
112 CitationsSource
#1Fernando Salvador (CSIC: Spanish National Research Council)H-Index: 7
#2Alberto Martin (CSIC: Spanish National Research Council)H-Index: 12
Last. Amparo Cano (CSIC: Spanish National Research Council)H-Index: 67
view all 15 authors...
The lysyl oxidase–like protein LOXL2 has been suggested to contribute to tumor progression and metastasis, but in vivo evidence has been lacking. Here we provide functional evidence that LOXL2 is a key driver of breast cancer metastasis in two conditional transgenic mouse models of PyMT-induced breast cancer. LOXL2 ablation in mammary tumor cells dramatically decreased lung metastasis, whereas LOXL2 overexpression promoted metastatic tumor growth. LOXL2 depletion or overexpression in tumor cells...
68 CitationsSource
#1Yekaterina A. Miroshnikova (UCSF: University of California, San Francisco)H-Index: 7
#2G. I. Rozenberg (UPenn: University of Pennsylvania)H-Index: 1
Last. Valerie M. Weaver (UCSF: University of California, San Francisco)H-Index: 87
view all 12 authors...
Author(s): Miroshnikova, YA; Rozenberg, GI; Cassereau, L; Pickup, M; Mouw, JK; Ou, G; Templeman, KL; Hannachi, E-I; Gooch, KJ; Sarang-Sieminski, AL; Garcia, AJ; Weaver, VM | Abstract: Tumors are fibrotic and characterized by abundant, remodeled, and cross-linked collagen that stiffens the extracellular matrix stroma. The stiffened collagenous stroma fosters malignant transformation of the tissue by increasing tumor cell tension to promote focal adhesion formation and potentiate growth factor rec...
32 CitationsSource
#1Armen H. Mekhdjian (Stanford University)H-Index: 7
#2FuiBoon Kai (UCSF: University of California, San Francisco)H-Index: 10
Last. Valerie M. Weaver (UCSF: University of California, San Francisco)H-Index: 87
view all 21 authors...
Metastasis requires tumor cells to navigate through a stiff stroma and squeeze through confined microenvironments. Whether tumors exploit unique biophysical properties to metastasize remains unclear. Data show that invading mammary tumor cells, when cultured in a stiffened three-dimensional extracellular matrix that recapitulates the primary tumor stroma, adopt a basal-like phenotype. Metastatic tumor cells and basal-like tumor cells exert higher integrin-mediated traction forces at the bulk and...
70 CitationsSource
#1Michael W. Pickup (Vandy: Vanderbilt University)H-Index: 23
#2Philip Owens (Vandy: Vanderbilt University)H-Index: 26
Last. Harold L. Moses (Vandy: Vanderbilt University)H-Index: 124
view all 3 authors...
Abstract The cellular and noncellular components surrounding the tumor cells influence many aspects of tumor progression. Transforming growth factor β (TGF-β), bone morphogenetic proteins (BMPs), and activins have been shown to regulate the phenotype and functions of the microenvironment and are attractive targets to attenuate protumorigenic microenvironmental changes. Given the pleiotropic nature of the cytokines involved, a full understanding of their effects on numerous cell types in many con...
33 CitationsSource
#1Matthew Hall (Cornell University)H-Index: 24
#2Farid Alisafaei (UPenn: University of Pennsylvania)H-Index: 13
Last. Mingming Wu (Cornell University)H-Index: 30
view all 7 authors...
Abstract In native states, animal cells of many types are supported by a fibrous network that forms the main structural component of the ECM. Mechanical interactions between cells and the 3D ECM critically regulate cell function, including growth and migration. However, the physical mechanism that governs the cell interaction with fibrous 3D ECM is still not known. In this article, we present single-cell traction force measurements using breast tumor cells embedded within 3D collagen matrices. W...
178 CitationsSource
#1Lee Ann Jolly (University of Arkansas for Medical Sciences)H-Index: 4
#2Sergey V. Novitskiy (Vandy: Vanderbilt University)H-Index: 27
Last. Aime T. Franco (University of Arkansas for Medical Sciences)H-Index: 12
view all 8 authors...
Contributions of the tumor microenvironment (TME) to progression in thyroid cancer are largely unexplored and may illuminate a basis for understanding rarer aggressive cases of this disease. In this study, we investigated the relationship between the TME and thyroid cancer progression in a mouse model where thyroid-specific expression of oncogenic BRAF and loss of Pten ( BrafV600E/Pten−/−/TPO-Cre ) leads to papillary thyroid cancers (PTC) that rapidly progress to poorly differentiated thyroid ca...
56 CitationsSource